# XERIS BIOPHARMA HOLDINGS INC (XERS)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/XERS/

- Reporting holders: 7
- Reported value: $12.3M
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Vilga Financial Planning LLC](https://holderbook.com/funds/2083456-vilga-financial-planning-llc/) | $10.1M | 1,060,000 | 6.0% | 1 |
| [Apella Capital, LLC](https://holderbook.com/funds/1801507-apella-capital-llc/) | $2.1M | 206,004 | 0.0% | 7 |
| [GK Wealth Management LLC](https://holderbook.com/funds/2069222-gk-wealth-management-llc/) | $31.6K | 3,310 | 0.0% | 1 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $28.4K | 2,973 | 0.0% | 12 |
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $7.8K | 814 | 0.0% | 7 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $2.9K | 306 | 0.0% | 3 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $2.0K | 209 | 0.0% | 5 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 7 | $12.3M |
| Q2 2026 | 244 | $931.7M |
| Q1 2026 | 235 | $627.6M |
| Q4 2025 | 228 | $802.3M |
| Q3 2025 | 231 | $806.8M |
| Q2 2025 | 202 | $427.6M |
| Q1 2025 | 202 | $486.4M |
| Q4 2024 | 164 | $224.5M |
| Q3 2024 | 147 | $184.9M |
| Q2 2024 | 138 | $138.5M |
| Q1 2024 | 144 | $142.1M |
| Q4 2023 | 121 | $147.2M |